This review evaluates the antihypertensive potential of sodium-glucose cotransporter-2 inhibitors (SGLT2-i) and glucagon-like peptide-1 receptor agonists (GLP-1RA), particularly in patients with comorbid diabetes, HF, CKD or resistant hypertension
We provide insurance verification to help you understand your coverage, potential copays, and out-of-pocket costs before starting treatment
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
Alternative health companies benefit from negative medication messaging
A set of monomeric near-infrared fluorescent proteins for multicolor imaging across scales
Third, the research failed to directly evaluate hepatic stellate cell activity or use special histology stains, such as Massons trichrome or Sirius Red, for enhanced fibrosis quantification